Nanovic Lisa, Becker Yolanda Tai, Hedican Sean, Hofmann R Michael
Department of Transplant Surgery, University of Wisconsin, Fitchburg, WI 53713, USA.
Am J Kidney Dis. 2005 Nov;46(5):e91-4. doi: 10.1053/j.ajkd.2005.08.009.
Causes of gross hematuria in a patient with end-stage renal disease are limited compared with those in patients with normal renal function. Given the increased likelihood of patients with end-stage renal disease developing renal cell carcinoma, the workup focuses on a careful evaluation of the collecting system. The workup for gross hematuria in a renal transplant recipient is similar; however, the focus shifts toward a more thorough evaluation of the transplanted kidney and bladder because immunosuppression increases the overall risk for malignancy. An immunosuppressed patient also is at risk for infectious processes in the transplanted kidney manifesting as gross hematuria. Concerns for chronic rejection also should be investigated, although microscopic hematuria is more common in this scenario. If this is unrevealing, then close scrutiny of the native kidneys for possible sources of bleeding is warranted. We present an interesting and unusual cause of painless gross hematuria in a patient with end-stage renal disease and transplant nephrectomy 3 months before the onset of bleeding.
与肾功能正常的患者相比,终末期肾病患者肉眼血尿的病因较为有限。鉴于终末期肾病患者发生肾细胞癌的可能性增加,检查重点在于对集合系统进行仔细评估。肾移植受者肉眼血尿的检查方法类似;然而,重点转向对移植肾和膀胱进行更全面的评估,因为免疫抑制会增加总体恶性肿瘤风险。免疫抑制患者的移植肾也有发生感染性病变并表现为肉眼血尿的风险。尽管在这种情况下镜下血尿更为常见,但也应调查慢性排斥反应的问题。如果未发现问题,那么有必要仔细检查原肾以寻找可能的出血来源。我们报告了一例终末期肾病患者在出血前3个月接受移植肾切除术后出现无痛性肉眼血尿的有趣且不寻常的病因。